| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/18/2000 | US6051693 Human monoclonal antibody which preferentially binds to neoplastic cell over a normal cell of same tissue type; for diagnosis, anticarcinogenic agents and antitumor agents |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051689 Receptor for the glucagon-like-peptide (GLP-1) |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051429 Peptide-enhanced cationic lipid transfections |
| 04/18/2000 | US6051418 Hybrid proteins with modified activity |
| 04/18/2000 | US6051406 Keratan sulfate 6-sulfotransferase and DNA coding for the same |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | US6051402 A nucleic acid encoding an anti-sickling beta-globin protein; gene therapy for sickle cell |
| 04/18/2000 | US6051401 Methods and constructs for protein expression |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051399 Production of C-terminal amidated peptides from recombinant protein constructs |
| 04/18/2000 | US6051396 Method for producing retinoblastoma gene protein products |
| 04/18/2000 | US6051387 Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies |
| 04/18/2000 | US6051384 Method of detecting p53-specific antibodies |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051232 Comprising allogenic chimeric major histocompatibility complex class i milecule; to induce tolerance to donor grafts when administered to the recipient at time of transplantation |
| 04/18/2000 | US6051230 For treatment and/or diagnosis (imaging) of vascularized solid tumors |
| 04/18/2000 | US6051229 Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions |
| 04/18/2000 | US6051227 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051225 Family of high affinity, modified antibodies for cancer treatment |
| 04/18/2000 | US6051222 Cancer diagnosis; genetic engineering |
| 04/18/2000 | US6051217 Administering to patient with hematopoietic or immunodeficiency |
| 04/18/2000 | CA2192184C Extraction of heterologous insoluble proteins from bacteria |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020609A2 Protective recombinant haemophilus influenzae high molecular weight proteins |
| 04/13/2000 | WO2000020607A2 Chimaeric proteins between members of tgf-beta superfamily |
| 04/13/2000 | WO2000020596A1 Fungal transcriptional activator useful in methods for producing polypeptides |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020590A2 G-protein coupled receptor proteins |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020576A2 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 04/13/2000 | WO2000020555A2 Transformation system in the field of filamentous fungal hosts: in chrysosporium |
| 04/13/2000 | WO2000020450A2 Calcium channel alpha-2/delta gene |
| 04/13/2000 | WO2000020449A2 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020444A1 Novel peptides |
| 04/13/2000 | WO2000020442A1 Tumor-specific antigen peptides |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | WO2000020011A1 Isolated dna encoding human h3 histamine receptor |
| 04/13/2000 | WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000003010A3 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 04/13/2000 | WO2000000634A3 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/13/2000 | WO1999055875A3 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
| 04/13/2000 | DE19852800C1 Production of antibodies to a polypeptide encoded by a known DNA sequence comprises binding of antibodies produced by DNA vaccination to immobilized recombinantly expressed polypeptide |
| 04/13/2000 | CA2657302A1 Modified tgf-.beta. superfamily proteins |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346496A1 Novel th2-specific molecules and uses thereof |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |
| 04/13/2000 | CA2345377A1 Novel secreted proteins and polynucleotides encoding them |
| 04/13/2000 | CA2345045A1 G-protein coupled receptor proteins |
| 04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |
| 04/13/2000 | CA2344765A1 Novel peptides |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | CA2341351A1 Alpha-2/delta gene |
| 04/12/2000 | EP0992588A1 DsbA/DsbB/DsbC/DsbD expression plasmid |
| 04/12/2000 | EP0992586A2 Extracellular matrix proteins with modified amino acid |
| 04/12/2000 | EP0992585A2 Human calcium channel compositions and methods |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0992512A2 Reduced cortisol conjugate |
| 04/12/2000 | EP0991946A1 Diagnostic assays using soluble endothelial cell protein c/activated protein c receptor |
| 04/12/2000 | EP0991774A1 Method for increasing secretion of proteins in eukaryotic host cells |
| 04/12/2000 | EP0991770A2 Prostate cancer gene |
| 04/12/2000 | EP0991761A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines |
| 04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
| 04/12/2000 | EP0991661A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 04/12/2000 | EP0814838A4 Antigen presenting system and methods for activation of t-cells |
| 04/12/2000 | EP0766825A4 Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 04/12/2000 | EP0676052B1 Detection of cystic fibrosis or a cftr gene mutation |
| 04/12/2000 | EP0452413B1 Generation and selection of novel dna-binding proteins and polypeptides |
| 04/12/2000 | EP0362218B2 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
| 04/12/2000 | CN1250484A Diagnosis and treatment of glaucoma |
| 04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
| 04/12/2000 | CN1250381A Remedies for lymphocytic tumors |
| 04/12/2000 | CN1250098A Human P47 coding series and the polypeptide therewith and its preparation |
| 04/12/2000 | CN1250097A New human gene coding series and the polypeptide therewith and its preparation |
| 04/12/2000 | CN1250096A New human protein phosphatase subunit and its coding series and preparation |
| 04/12/2000 | CN1250095A New human gene series and the polypeptide therewith and its preparation |
| 04/12/2000 | CN1250094A New human kernon acceptor co-repressor coding series and the polypeptide therewith and its preparation |
| 04/12/2000 | CN1250055A Production of recombination human lactoferritin |
| 04/11/2000 | US6048972 Polynucleotide sequences which code for reshaped human monoclonal antibody preferential to interleukins |
| 04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
| 04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048714 Nematode pesticide isolated from fungus |
| 04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
| 04/11/2000 | US6048700 Detecting the presence of a bordetella antigen in a sample; contacting an antibody specific antigen with said sample and detecting binding of an antibody to bordetta antigen, binding of the antbody is an indicator of presence of antigen |
| 04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
| 04/11/2000 | US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
| 04/11/2000 | CA2009579C Insulin analogs |
| 04/11/2000 | CA1340953C Non-tumorigenic cell lines for expression of genes |